Username Password
S&P 500: 1,351.68 Change: +0.14%

ANADYS PHARMACEUTICALS INC. (ANDS)

Overview
Price 3.70
Price Change Today 0.00 (0.00%)
P&P rating Rating: 4
Open Price $3.69
Previous Close $3.70
Daily Range $3.69 - $3.70
52-Week Range $0.60 - $3.70
Volume 169
chart
Other Resources for ANDS
zacks.com
Commentary
Zacks Blog: Concur Joins Cloud Network
May 12, 2011
NetSuite, Inc. is the leading provider of on-demand, integrated business management software for growing and midsize businesses. With thousands of customers globally using NetSuite's online products and professional services, companies are enabled to manage all key business operations in a single hosted system, including: customer relationship management; order fulfillment; inventory; accounting and finance, product assembly; ecommerce; Web site management; and employee productivity.
 
Brokerage Analyst Recommendations
20 Brokerage Firms Covering N
 
    
Strong Buy
4
Buy
2
Hold
13
Sell
0
Strong Sell
1
Average Broker Recommendation (ABR): 2.55
 
N Ratings:BUY  SELL  HOLD
Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

17 Buy
0 Sell
 
Top Buy Analysis
BUY: ANDS Rating: 4
Company: ANADYS PHARMACEUTICALS INC.
Points: -94.01
Start Price: $5.01
Start Date: 01/17/2009 10:41 PM
anab
anab
P&P Score: 0.00
Recs:
There is a need for HEP C vaccine/cure. Blind study went well. Will make money and has a patent on drug. You will make money. I purchased this stock for my daughter and it has more than doubled in just a couple of months! Buy now!

Comments: 1 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 10/17/11 Roche Targets Anadys Pharma - Analyst Blog 0
Zacks_Analysts
0.00 03/08/11 Anadys Narrows Loss - Analyst Blog 0
Zacks_Analysts
0.00 05/24/10 Good News for Anadys - Analyst Blog 0
Zacks_Analysts
0.00 04/16/10 Anadys Reports Positive Data - Analyst Blog 0
Zacks_Analysts
0.00 12/18/09 Anadys Drug Meets Key Study Goals - Analyst Blog 0
Zacks_Analysts
0.00 09/25/09 Mid-Stage Study for Anadys Drug - Analyst Blog 0
Zacks_Analysts
0.00 09/11/09 Anadys Begins Mid-Stage Trial - Analyst Blog 0
Zacks_Analysts
0.00 07/31/09 Anadys Reports Narrower Loss - Analyst Blog 0
Zacks_Analysts
0.00 07/22/09 Earnings Preview: Anadys - Analyst Blog 0
Commentary
BUY: ANADYS PHARMACEUTICALS INC. (ANDS) Rating: 4
Start Price: $3.08
Points: -37.50
Created: 04/26/2009
This stock is going back up.A false alarm is what made it go down in the first
place.

Comments: 0 | Comment

Recs:
 
BUY: ANADYS PHARMACEUTICALS INC. (ANDS) Rating: 4
Start Price: $5.01
Points: -94.01
Created: 01/17/2009
There is a need for HEP C vaccine/cure. Blind study went well. Will make money and has a patent on drug. You will make money. I purchased this stock for my daughter and it has more than doubled in just a couple of months! Buy now!

Comments: 1 | Comment

Recs:
 
BUY: ANADYS PHARMACEUTICALS INC. (ANDS) Rating: 4
Start Price: $11.83
Points: -60.80
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ANADYS PHARMACEUTICALS INC. (ANDS) Rating: 4
Start Price: $3.20
Points: +23.55
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ANADYS PHARMACEUTICALS INC. (ANDS) Rating: 4
Start Price: $10.28
Points: -56.09
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ANADYS PHARMACEUTICALS INC. (ANDS) Rating: 4
Start Price: $3.30
Points: +20.04
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ANADYS PHARMACEUTICALS INC. (ANDS) Rating: 4
Start Price: $4.74
Points: -14.02
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ANADYS PHARMACEUTICALS INC. (ANDS) Rating: 4
Start Price: $14.65
Points: -66.82
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ANADYS PHARMACEUTICALS INC. (ANDS) Rating: 4
Start Price: $14.97
Points: -67.36
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ANADYS PHARMACEUTICALS INC. (ANDS) Rating: 4
Start Price: $2.93
Points: +34.20
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
uwork4u BUY Week to a Month 04/26/2009 $3.08 $3.70
(0.00%)
+20.13% +57.63% -37.50 view
anab BUY Week or Less 01/17/2009 $5.01 $3.70
(0.00%)
-26.15% +67.86% -94.01 view
Chak 21.03 BUY Six Months to a Year 01/01/2008 $11.83 $3.70
(0.00%)
-68.72% -7.92% -60.80
ChrisCH 62.80 BUY Six Months to a Year 01/01/2008 $3.20 $3.70
(0.00%)
+15.62% -7.92% +23.55
Vayloe 53.71 BUY Six Months to a Year 01/01/2008 $10.28 $3.70
(0.00%)
-64.01% -7.92% -56.09
ZacksChallenge1 43.51 BUY Six Months to a Year 01/01/2008 $3.30 $3.70
(0.00%)
+12.12% -7.92% +20.04
GABEBROWN 53.62 BUY Six Months to a Year 01/01/2008 $4.74 $3.70
(0.00%)
-21.94% -7.92% -14.02
2000 41.69 BUY Six Months to a Year 01/01/2008 $14.65 $3.70
(0.00%)
-74.74% -7.92% -66.82
spatel 27.37 BUY Six Months to a Year 01/01/2008 $14.97 $3.70
(0.00%)
-75.28% -7.92% -67.36
teos35 40.97 BUY Six Months to a Year 01/01/2008 $2.93 $3.70
(0.00%)
+26.28% -7.92% +34.20
Pages: [ 1 ]  2  >>
Sponsored Links